{
  "id": "OPM-2025-0004-1373",
  "title": "Comment from Deborah  Seifert",
  "category": "Agency",
  "analysis": {
    "stance": "Against",
    "themes": [
      "Merit-based system concerns",
      "Due process/employee rights",
      "Politicization concerns",
      "Institutional knowledge loss"
    ],
    "key_quote": "Adoption of this proposed rule will harm biomedical industry and innovation in the US and curtail our role as global leaders in science and technology.",
    "rationale": "The comment explicitly opposes the proposed rule, emphasizing the importance of nonpartisan civil servants and the potential negative impact on expertise and innovation, which aligns with concerns about politicization and the merit-based system."
  },
  "occurrence_number": 0,
  "duplicate_of": ""
}